drugset

drugset / Trial / NCT02239094

Biosignatures of Latuda for Bipolar Depression

NCT02239094 ↗

Completed 20 enrolled New York State Psychiatric Institute Sumitomo Pharma America, Inc. · collab

NaSingle-groupOpen-labelTreatment

Summary

The study proposes to conduct a pilot study of biological predictors of lurasidone response in bipolar depression.

Timeline

Start: 2015-01
Primary completion: 2016-09
Completion: 2016-09

Publications

Lan MJ, Pantazatos SP, Ogden RT, Rubin-Falcone H, Hellerstein D, McGrath PJ, Mann JJ. Resting State MRI Amplitude of Low Frequency Fluctuations Associated With Suicidal Ideation in Bipolar Depression. J Clin Psychiatry. 2022 Mar 30;83(3):21m14054. doi: 10.4088/JCP.21m14054.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lurasidone	Small molecule	—	—

Indications